Shire Sues Alkem Over Fosrenol Patents
Pharmaceutical giant Shire Canada Inc. has launched two parallel infringement suits against Alkem Laboratories Ltd. over its bid to introduce a generic version of kidney failure treatment Fosrenol....To view the full article, register now.
Already a subscriber? Click here to view full article